2BB score and signals
Larimar Therapeutics, Inc.’s current 2BB score is 47 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 57 | Moderate |
| Momentum | 59 | Stable |
| Financial strength | 15 | Very Weak |
| Quality | 82 | Very Strong |
| Risk | 60 | High |
Company facts
| Headquarters | Bala Cynwyd, Pennsylvania, United States |
| Founded | 2005 |
| Employees | 71 |
| 52-week range | $2.06 – $6.42 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-17 | — | -0.3852 | — | $0.00 |
| 2026-11-05 | — | -0.351 | — | $0.00 |
| 2026-08-06 | — | -0.3888 | — | $0.00 |
| 2026-05-14 | -0.31 | -0.5457 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish